Search

Newsletter image

Subscribe to the Newsletter

Join 10k+ people to get notified about new posts, news and tips.

Do not worry we don't spam!

GDPR Compliance

We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policy, and Terms of Service.

12,000 women diagnosed with cervical cancer annually – Minister

Published on April 21, 2025 at 06:58 AM

About 12,000 Nigerian women are diagnosed with cervical cancer annually, despite the disease being largely preventable, the Coordinating Minister of Health and Social Welfare, Dr Mohammed Ali Pate, has disclosed.

The Minister made the disclosure during the launch of the cervical cancer vaccine campaign and the Human Papillomavirus (HPV) vaccine integration sensitisation exercise held at Government Girls College, Bauchi.

According to him, “There is the need for greater awareness among stakeholders as part of efforts to eliminate cervical cancer in Bauchi State and across Nigeria.”

With the HPV vaccine, Pate stated that the disease can be prevented if vaccination is administered early to individuals who are susceptible to the virus and at risk of eventually developing cervical cancer.

He assured the commitment of the President to the cause and recalled the official flag-off of the HPV vaccination campaign in October 2023.

The Director-General of the National Institute for Cancer Research and Treatment, Dr Usman Malami, in his remarks, explained that cervical cancer is one of the few cancers with a known cause.

He added that it makes it one of the most preventable forms of cancer, stressing that since they already know what causes it and what can provide lifelong immunity, vaccination becomes a critical tool.

Prev Article

Heartbreak as ‘athletic’ woman, 25, dies after lower back pain blamed on ‘poor posture’ was misdiagnosed as sciatica

Next Article

Urgent warning for Glastonbury ticket hopefuls over resale mistake that costs you hundreds if you miss sign

Related to this topic:

Comments (0):

Be the first to write a comment.

Post Comment

Your email address will not be published. Required fields are marked *